Rgls stock price target
RGLS has been the topic of a number of other research reports. Zacks Investment Research raised shares of Regulus Therapeutics from a “hold” rating to a “buy” rating and set a $0.75 target price on the stock in a research report on Wednesday, November 20th. HC Wainwright initiated coverage on shares of Regulus Therapeutics in a research note on Friday, September 6th. Regulus Therapeutics’ (RGLS) Hold Rating Reaffirmed at ... Wedbush reissued their hold rating on shares of Regulus Therapeutics (NASDAQ:RGLS) in a research report report published on Thursday morning, AnalystRatings.com reports. They currently have a $1.00 target price on the biopharmaceutical company’s stock. RGLS has been the topic of several other research reports. Regulus Therapeutics (NASDAQ:RGLS) Ratings | Benzinga Jan 01, 2010 · Regulus Therapeutics (NASDAQ: RGLS) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Regulus Therapeutics Inc., RGLS Quick Chart - (NAS) RGLS ... Regulus Therapeutics stock price target cut to $6 from $8 at Wedbush Securities MarketWatch. Tuesday, June 28, 2016. 04:42 PM ET. Dow jumps 269 points, reclaims a portion of 2-day Brexit-induced rout MarketWatch. 07:23 AM ET. Regulus Therapeutics stock price target cut to $15 from $35 at Wedbush Securities MarketWatch. Monday, June 27, 2016. 04
by multiplying the current stock price by the number of shares outstanding. and developing drugs that target microRNAs, called microRNA therapeutics.
Regulus Therapeutics (NASDAQ:RGLS) Ratings | Benzinga Jan 01, 2010 · Regulus Therapeutics (NASDAQ: RGLS) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Regulus Therapeutics Inc., RGLS Quick Chart - (NAS) RGLS ... Regulus Therapeutics stock price target cut to $6 from $8 at Wedbush Securities MarketWatch. Tuesday, June 28, 2016. 04:42 PM ET. Dow jumps 269 points, reclaims a portion of 2-day Brexit-induced rout MarketWatch. 07:23 AM ET. Regulus Therapeutics stock price target cut to $15 from $35 at Wedbush Securities MarketWatch. Monday, June 27, 2016. 04
Equities Analysts Offer Predictions for Regulus ...
Wall Street analysts forecast that Regulus Therapeutics Inc (NASDAQ:RGLS) will report $5.01 million in sales for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Regulus Therapeutics’ earnings, with the highest sales estimate coming in at $10.00 million and the lowest estimate coming in at $20,000.00.
In-depth view of key statistics and finances for REGULUS THERAPEUTICS INC. (RGLS) on MSN Money.
Nov 06, 2019 · 3 Wall Street analysts have issued ratings and price targets for Regulus Therapeutics in the last 12 months. Their average twelve-month price target is $1.50, suggesting that the stock has a possible upside of 215.06%. The high price target for RGLS is … RGLS Regulus Therapeutics Inc. Common Stock - NASDAQ.com Regulus Therapeutics Inc. Common Stock (RGLS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Regulus Therapeutics Inc. (RGLS) Stock Price, Quote ... Find the latest Regulus Therapeutics Inc. (RGLS) stock quote, history, news and other vital information to help you with your stock trading and investing. RGLS Price Target | Regulus Stock Forecast & Ratings
Regulus Therapeutics Inc. (RGLS) Interactive Stock Chart ...
Equities Analysts Offer Predictions for Regulus ... RGLS has been the topic of a number of other research reports. Zacks Investment Research raised shares of Regulus Therapeutics from a “hold” rating to a “buy” rating and set a $0.75 target price on the stock in a research report on Wednesday, November 20th. HC Wainwright initiated coverage on shares of Regulus Therapeutics in a research note on Friday, September 6th. Regulus Therapeutics’ (RGLS) Hold Rating Reaffirmed at ... Wedbush reissued their hold rating on shares of Regulus Therapeutics (NASDAQ:RGLS) in a research report report published on Thursday morning, AnalystRatings.com reports. They currently have a $1.00 target price on the biopharmaceutical company’s stock. RGLS has been the topic of several other research reports. Regulus Therapeutics (NASDAQ:RGLS) Ratings | Benzinga Jan 01, 2010 · Regulus Therapeutics (NASDAQ: RGLS) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on
Regulus Therapeutics Inc Stock Quote: RGLS Stock News ... Nov 05, 2019 · RGLS, Regulus Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Stock Comparison: Compare Regulus Therapeutics Inc. (RGLS ... Online Stock Comparison - Compare Regulus Therapeutics Inc. (RGLS) to four other stocks with NASDAQ.com's stock comparison tool.